Evidence map›Paper›PMID 41196411›Full record

ArticleCellular and molecular life sciences : CMLS2025

Restoring compromised blood-retina-barrier integrity with Netrin-1 overexpression.

Jessica Furtado, Thomas E Zapadka, Hyojin Park, Kevin Boyé, Jonathan B Demb, Anne Eichmann

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jessica FurtadoDepartment of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, 06511, USA.ORCID http://orcid.org/0000-0002-7975-2592
Thomas E ZapadkaDepartment of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, 06511, USA.
Hyojin ParkCardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 06511, USA.
Kevin BoyéParis Cardiovascular Research Center, Inserm U970, Université Paris, Paris, France.
Jonathan B DembDepartment of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, 06511, USA.
Anne EichmannDepartment of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, 06511, USA. anne.eichmann@yale.edu.ORCID http://orcid.org/0000-0001-5563-210X

Funding

Yale Core Grant for Vision ResearchP30EY026878 · NEI · YALE UNIVERSITY · PI Jonathan B Demb · 2016 to 2026
$7.1M
Targeting endothelial migration to prevent neovascularizationR01HL125811 · NHLBI · YALE UNIVERSITY · PI EICHMANN, ANNE CHRISTINE · 2015 to 2025
$4.1M
American Heart Association 830299European Research Council 834161NEI NIH HHS P30 EY026878NHLBI Division of Intramural Research 1R01HLI125811NHLBI NIH HHS R01 HL125811
6 · The paper itself

Abstract

The blood-retina barrier (BRB) protects retinal neuronal function and enables vision. A compromised, leaky BRB is a hallmark of vision-threatening retinal diseases such as diabetic retinopathy (DR) and wet age-related macular degeneration (AMD) that affect millions of persons worldwide. Strategies to enhance BRB integrity hold promise as therapeutic interventions to prevent vision loss. Previous studies identified Netrin-1 (NTN1) as a key regulator of BRB stability and revealed reduced Netrin-1 signaling in DR patients, suggesting that Netrin-1 supplementation could help preserve BRB function and prevent disease progression. Herein, we used inducible genetic NTN1 overexpression to investigate effects on BRB development and maintenance. We show that global NTN1 overexpression converted leaky vessels at the P5 angiogenic front into a non-leaky state. In pathological settings, NTN1 overexpression reinforced BRB integrity in oxygen-induced retinopathy (OIR), improving electroretinogram (ERG) amplitudes and rescued vascular leak in laser-induced choroidal neovascularization (CNV). NTN1 overexpression or Ntn1 knockout minimally and transiently affected retinal angiogenesis. Global Unc5b deletion phenocopied vascular leak observed in Ntn1 deficient retinas, while angiogenesis defects differed between Ntn1 and Unc5b knockouts. These findings establish Netrin-1 as a promising therapeutic target for preventing BRB breakdown in retinal vascular diseases and suggest that reinforcing the Netrin-1/Unc5b signaling pathway may provide a strategy to selectively stabilize the BRB.

Indexed as

Blood-Retinal BarrierNetrin-1AnimalsChoroidal NeovascularizationDiabetic RetinopathyElectroretinographyHumansMiceMice, Inbred C57BLMice, KnockoutNetrin ReceptorsRetinaNetrin-1Netrin ReceptorsNtn1 protein, mouseAge-related macular degeneration (AMD)Blood-retina-barrier (BRB)Diabetic retinopathy (DR)Netrin-1

Identifiers

PMID41196411
PMCPMC12592616

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.